SCHEMBL21670879

SCHEMBL21670879

Cc1cc(C)c(/N=C/c2cc(-c3ccccc3)n(C)n2)c(C)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.34
MAPT P10636 4/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
DDB1 Q16531 2/20 0.34
CRBN Q96SW2 2/20 0.34
STAT3 P40763 1/20 0.33
GAA P10253 1/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
SRC P12931 1/20 0.32
ALDH1A1 P00352 2/20 0.32
PSMB5 P28074 2/20 0.32
POLB P06746 1/20 0.32
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
BRD4 O60885 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21670865 0.79 GRM5 (0.33) GRM5NPC1RAB9ADDB1CRBN
SCHEMBL14293370 0.71 GRM5 (0.41) GRM5MAPTNPSR1NPC1RAB9A
SCHEMBL1780239 0.71 DDB1 (0.43) GRM5NPC1RAB9ADDB1CRBN
SCHEMBL21670863 0.71 ALDH1A1 (0.35) MAPTHTTNPSR1NPC1RAB9A
SCHEMBL6913232 0.70 MAOA (0.47) GRM5MAPTHTTNPSR1NPC1
SCHEMBL6913236 0.70 MAOA (0.47) GRM5MAPTHTTNPSR1NPC1
SCHEMBL5588352 0.70 ALDH1A1 (0.38) MAPTHTTNPSR1NPC1GAA
SCHEMBL5588346 0.70 ALDH1A1 (0.38) MAPTHTTNPSR1NPC1GAA
SCHEMBL13041054 0.69 P2RY1 (0.34) GRM5NPC1RAB9ADDB1CRBN
SCHEMBL11048071 0.69 ALDH1A1 (0.46) MAPTHTTNPSR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11708429-B2 Bidentate azolylamido metal-ligand complexes and olefin polymerization catalysts DOW GLOBAL TECHNOLOGIES LLC (US) 2023-07-25 US disclosed
US-11708429-B2 Bidentate azolylamido metal-ligand complexes and olefin polymerization catalysts DOW GLOBAL TECHNOLOGIES LLC (US) 2023-07-25 US disclosed
US-20210332165-A1 BIDENTATE AZOLYLAMIDO METAL-LIGAND COMPLEXES AND OLEFIN POLYMERIZATION CATALYSTS DOW GLOBAL TECHNOLOGIES LLC (US) 2021-10-28 US disclosed
WO-2020028240-A1 BIDENTATE AZOLYLAMIDO METAL-LIGAND COMPLEXES AND OLEFIN POLYMERIZATION CATALYSTS DOW GLOBAL TECHNOLOGIES LLC (US) 2020-02-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11708429-B2 Bidentate azolylamido metal-ligand complexes and olefin polymerization catalysts LIG4, PARG, PIN1 GRM5 2810/4885MAPT 410/4885HTT 2939/4885
US-20210332165-A1 BIDENTATE AZOLYLAMIDO METAL-LIGAND COMPLEXES AND OLEFIN POLYMERIZATION CATALYSTS LIG4, PARG, PIN1 GRM5 2810/4885MAPT 410/4885HTT 2939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.